Malignant thymoma (MT) is a rare tumor that is often associated with myasthenia gravis (MG). This tumor is considered resistant to chemotherapy. We had the opportunity to treat five patients with MT with cyclophosphamide 800 mg/m2, Adriamycin 50 mg/m2, and vincristine 1.4 mg/m2 (CAV) in cycles of 21
β¦ LIBER β¦
The diagnosis of thymoma in myasthenia gravis
β Scribed by J. A. Aarli
- Publisher
- Springer Milan
- Year
- 1983
- Tongue
- English
- Weight
- 645 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1590-1874
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Chemotherapy in thymoma and myasthenia g
β
P. A. Kosmidis; E. Iliopoulos; S. Pentea
π
Article
π
1988
π
John Wiley and Sons
π
English
β 519 KB
Thymoma with myasthenia gravis in a dog
β
G. A. Hall; J. Mcc. Howell; D. G. Lewis
π
Article
π
1972
π
John Wiley and Sons
π
English
β 506 KB
Myasthenia gravis following extirpation
β
Theodore Ehrenreich; Arthur C. Allen
π
Article
π
1958
π
John Wiley and Sons
π
English
β 996 KB
Myasthenia gravis induces the activation
β
Keiji Takahashi; Yasumasa Monden; Seiya Saito; Yoshitaka Kamamura; Tadashi Uyama
π
Article
π
1996
π
Springer
π
English
β 657 KB
The laboratory diagnosis of mild myasthe
β
Dr John J. Kelly Jr; Jasper R. Daube; Vanda A. Lennon; Frank M. Howard Jr; Brian
π
Article
π
1982
π
John Wiley and Sons
π
English
β 496 KB
π 1 views
## Abstract We report our experience with singleβfiber electromyogrphy (SFβEMG), acetylcholine receptor antibody assays, and Lancaster RedβGreen tests of ocular motility with edrophonium chloride in the diagnosis of myasthenia gravis (MG). Over a period of almost 3 years, 43 patients in whom repeti
Ryanodine receptor autoantibodies in mya
β
Dr Γ
se Mygland; Ole-BjΓΈrn Tysnes; Johan A. Aarli; Nils Erik Gilhus; Roald Matre;
π
Article
π
1992
π
John Wiley and Sons
π
English
β 357 KB
π 1 views